Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories is positioned for durable fundamental growth because it is expanding higher-margin licensing through Atmos, Vision, and image patent offerings that can raise royalties per device and reduce dependence on unit shipment cycles. Management’s progress in new growth vectors such as Atmos Auto, VDP, and OptiView adds revenue opportunities that are partly independent of consumer device demand, while the premium licensing mix is already approaching 50% of license revenue from 23% in FY21. Strong cash generation, a 2.7% dividend yield, and $150 million of remaining repurchase authorization further support the outlook, even as the core foundational business remains tied to a choppy macro environment.

Dolby Laboratories is viewed negatively because its licensing-driven revenue depends heavily on accurately forecasting customer device shipments, leaving results exposed to supply chain disruptions that can sharply reduce management’s visibility. Semiconductor availability is a particular risk, since chip shortages can delay or limit Dolby’s ability to attach its technologies to new devices, directly pressuring future licensing volumes. With revenue concentrated in technology and patent licensing, even modest interruptions in device production can meaningfully weaken growth and make performance less predictable.